Vaccines and Therapeutic Developments
A section of Pathogens (ISSN 2076-0817).
Section Information
The Covid-19 pandemic has dramatically exposed the shortcomings of our health and research systems when confronted with an unexpected new challenge. Vaccine development and new therapeutic strategies to fight old, re-emerging, and new infectious diseases represent the focus of this Section of Pathogens, with the ultimate aim to contribute to global health improvement. Human and veterinary vaccine and therapeutic advancements with regard to basic and clinical aspects for bacterial, viral, fungal and parasitic diseases will be considered. Contributions delineating survival and fatal outcomes, and correlates of protection are particularly encouraged. Novel delivery approaches, carrier/adjuvant systems and immunomodulatory therapy are also welcome.
Main topics include (but are not limited to):
Basic immunology and animal models
Vaccine design and technology
Therapy and vaccine delivery, safety and efficacy assessment
Human and veterinary vaccines for bacterial, fungal, viral, parasitic diseases
Immunotherapeutic developments
New approaches to therapy, novel druggable candidates and strategies
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Host-Parasite Interactions during Malaria Transmission (Deadline: 31 January 2021)
- New Insights in Acanthamoeba (Deadline: 31 January 2021)
- Latest Research on Prion Diseases (Deadline: 31 January 2021)
- A Disease with Dual Impacts: Leptospirosis in Humans and Livestock (Deadline: 31 January 2021)
- Current Status of Acinetobacter Infections (Deadline: 28 February 2021)
- Epidemiology, Surveillance and Control of Infectious Diseases (Deadline: 31 March 2021)
- Immunomodulation in Human Chlamydia Vaccines (Deadline: 31 March 2021)
- Immunity and Vaccine Development Efforts against Trypanosomatid Parasites (Deadline: 31 March 2021)
- Updates on Rickettsia and Coxiella (Deadline: 31 March 2021)
- Pneumococcus and Pneumococcal Vaccines (Deadline: 30 April 2021)
- Current Research on Hard Tick-Borne Diseases (Deadline: 30 April 2021)
- Meningococcal Disease in the Era of Multivalent Vaccines: Where Are We Now and Can We Do Better? (Deadline: 30 April 2021)
- Uncommon Candida and Other Opportunistic Yeast-Like Fungi: Diagnosis and Treatment (Deadline: 30 April 2021)
- Diagnostics and Surveillance of Arboviral Diseases (Deadline: 30 April 2021)
- Current Research on Dengue Vaccine (Deadline: 31 May 2021)
- Current and Future Strategies for VLP-Based Vaccines (Deadline: 31 May 2021)
- Research Advances in Melioidosis—A Neglected Tropical Infectious Disease (Deadline: 31 May 2021)
- Reviews from Section "Vaccines and Therapeutic Developments" (Deadline: 31 May 2021)
- Arthropod Vectors and Vector-Borne Diseases: A One Health Perspective (Deadline: 31 May 2021)
- Immune Responses to Emerging Viruses (Deadline: 30 June 2021)
- Detection and Characterization of Drug-Resistant Organisms (Deadline: 30 June 2021)
- Advances in Fish Virology: Emerging Viruses and Novel Techniques (Deadline: 31 July 2021)
- Coronaviruses and Other Human Respiratory Viruses from “Regular” Circulating Agents to Emerging Pathogens and the One Health Concept (Deadline: 31 August 2021)
- Allergy and Immunotherapy (Deadline: 31 August 2021)
- Fish Parasites and Immunology (Deadline: 31 August 2021)
- Cancer Vaccines: Design Considerations and Recent Advances (Deadline: 31 August 2021)
- Alveolar Echinococcosis: Joining Hands to Tackle a Lethal Parasitosis (Deadline: 30 September 2021)
- Novel Vaccine Strategies against Intracellular Bacteria (Deadline: 30 September 2021)
- Current Research on HIV Drug Resistance (Deadline: 31 October 2021)
- Biomarkers and Therapeutics for Parkinson's Disease (Deadline: 30 November 2021)